These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8906591

  • 1. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac ceramide and its substrate property toward hydrolases.
    Tsuchihashi K, Daino T, Akino T, Gasa S.
    J Lipid Res; 1996 Oct; 37(10):2136-44. PubMed ID: 8906591
    [Abstract] [Full Text] [Related]

  • 2. Novel modification of ceramide: rat glioma ganglioside GM3 having 3-O-acetylated sphingenine.
    Suetake K, Tsuchihashi K, Inaba K, Chiba M, Ibayashi Y, Hashi K, Gasa S.
    FEBS Lett; 1995 Mar 20; 361(2-3):201-5. PubMed ID: 7698323
    [Abstract] [Full Text] [Related]

  • 3. Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide.
    Daino T, Tsuchihashi K, Kashiwagi M, Yachida Y, Akino T, Gasa S.
    Glycoconj J; 1999 Jan 20; 16(1):39-43. PubMed ID: 10580649
    [Abstract] [Full Text] [Related]

  • 4. Characterization of novel mono-O-acetylated GM3s containing 9-O-acetyl sialic acid and 6-O-acetyl galactose in equine erythrocytes.
    Yachida Y, Tsuchihashi K, Gasa S.
    Glycoconj J; 1996 Apr 20; 13(2):225-23. PubMed ID: 8737247
    [Abstract] [Full Text] [Related]

  • 5. Novel di-O-acetylated GM3s from equine erythrocytes, one containing 4,9-di-O-acetyl-N-glycolylneuraminic acid and another containing 4-O-acetyl-N-glycolylneuraminic acid and 6-O-acetyl-D-galactose.
    Yachida Y, Tsuchihashi K, Gasa S.
    Carbohydr Res; 1997 Mar 05; 298(3):201-12. PubMed ID: 9090814
    [Abstract] [Full Text] [Related]

  • 6. Improved preparation method for lysogangliosides.
    Gasa S, Kamio K, Makita A.
    J Lipid Res; 1992 Jul 05; 33(7):1079-84. PubMed ID: 1431585
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds.
    Nores GA, Hanai N, Levery SB, Eaton HL, Salyan EK, Hakomori S.
    Carbohydr Res; 1988 Aug 15; 179():393-410. PubMed ID: 3208248
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An efficient synthesis of ganglioside GM3: highly stereocontrolled glycosylations by use of auxiliaries.
    Numata M, Sugimoto M, Ito Y, Ogawa T.
    Carbohydr Res; 1990 Aug 15; 203(2):205-17. PubMed ID: 2276123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of ganglioside GM3 and GM4 analogs having mimics of ceramide moieties and their binding activities with influenza virus A.
    Nagao Y, Nekado T, Ikeda K, Achiwa K.
    Chem Pharm Bull (Tokyo); 1995 Sep 15; 43(9):1536-42. PubMed ID: 7586078
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds.
    Nores GA, Hanai N, Levery SB, Eaton HL, Salyan ME, Hakomori S.
    Methods Enzymol; 1989 Sep 15; 179():242-53. PubMed ID: 2622350
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of isotopically radiolabelled GM3 ganglioside to study metabolic alterations in Salla disease.
    Chigorno V, Valsecchi M, Nicolini M, Sonnino S.
    Indian J Biochem Biophys; 1997 Sep 15; 34(1-2):150-6. PubMed ID: 9343943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.